let's get real for a momentThe coronavirus outbreak is going to get much worse and there is no chance in the world that this will end in April. Expect the issue to continue to get worse for the next 4-6 months. I expect that 30 - 60% of people in North America will get this virus and 2% or so will die. Most will be elderly. The market could begin to rebound after the initial panic period is over, when it does, profitable companies will see very significant gains. As long as Valens holds the course and can make $50M or more per year in profits it will deserve ia >$500M market cap, if not more. If management is smart, and I truely believe they are, they will use this period of low share price to buy back shares cheaply and make the rest of our shares more profitable.
In terms of the vaping issue, the team at Supra R&D has been working hard on this, developing an understanding of the problems that result in lung damage. They are developing new testing protocols so that issues like Vitamin E Acetate do not occur again. The cannabis extracts are not the problem here, but using the wrong additatives and heating too hot will create a toxic mess, that should not be consumed. However, vaping near 180C should not cause these types of problems and if you want a rule of thumb, never vape above 420F (~215C). Once this science get's out there, I believe that the vaping market will be back on track as a growth sector.
The work Valens has done regarding the beverage products is inspired. They will ultimately be one of the leaders in the game of thrones for Cannabis companies, in my humble opinion.